Title:
Clinicopathological study of renal amyloidosis

dc.contributor.authorUsha
dc.contributor.authorRana Gopal Singh
dc.contributor.authorJai Parkash
dc.contributor.authorRuchi Kapoor
dc.contributor.authorSunita Rai
dc.contributor.authorD.K. Sinha
dc.date.accessioned2026-02-07T04:45:13Z
dc.date.issued2006
dc.description.abstractStudy included 13 cases of renal amyloidosis. Oedema, feet and face was the commonest manifestation (100%), two patients (18.18%) also presented with loose motions, ascites and pain in abdomen and one patient had ankylosing spondylitis and cervical spondylitis. On clinical grounds only one case was diagnosed as primary amyloidosis of light chain type, who presented initially with cervical lymphadenopathy and 4 years later with nephrotic syndrome. About 72.72% cases had some chronic disease in the terms of tuberculosis, ankylosing spondylitis, chronic ulcerative colitis, lepromatous leprosy, rheumatoid arthritis and one patient had carcinoma caecum. Congo red stain was positive in both, light chain deposit disease (LCDD) and amyloidosis but polarizing microscope showed mixed birefringence (red, green, yellow) only in amyloidosis. In AFOG and PAS stain, amyloid appeared negative, only peripheral portion revealed blue and pink staining and central area appeared as cutout spaces. Congo red and methyl violet stains and potassium permanganate treatment was not helpful in distinguishing AL amyloidosis from secondary amyloidosis. Hence immunohistochemistry and myeloma profile is a must. It might be possible that in light chain amyloidosis, treatment with methotrexate and prednisolone may improve survival.
dc.identifier.issn9721177
dc.identifier.urihttps://dl.bhu.ac.in/bhuir/handle/123456789/18990
dc.subjectAmyloidosis
dc.subjectLight chain deposition disease
dc.subjectTuberculosis
dc.titleClinicopathological study of renal amyloidosis
dc.typePublication
dspace.entity.typeArticle

Files

Collections